Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia

G Menashe, A Borer, P Yagupsky, N Peled… - … Journal of infectious …, 2001 - Taylor & Francis
During an 8-month period, 55 episodes of nosocomial bacteremia caused by
Enterobacteriaceae species were identified in a tertiary medical center, of which 26 (47%) …

Influx of extended-spectrum β-lactamase—producing Enterobacteriaceae into the hospital

R Ben-Ami, MJ Schwaber… - Clinical infectious …, 2006 - academic.oup.com
Background. The prevalence of infections caused by extended-spectrum β-lactamase
(ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria …

Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum β-lactamase: a prospective cohort …

O Sianipar, W Asmara, I Dwiprahasto, B Mulyono - BMC Research Notes, 2019 - Springer
Objective Several studies reported that infection of extended-spectrum β lactamase (ESBL)-
producing Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae) contributed …

[HTML][HTML] Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and …

JT Freeman, SJ McBride, MS Nisbet… - International Journal of …, 2012 - Elsevier
OBJECTIVES: To define local risk factors and outcomes for bacteremia with extended-
spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) at a tertiary hospital in …

[PDF][PDF] Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

M Shanthi, U Sekar - J Assoc Physicians India, 2010 - academia.edu
Abstract Background: Extended spectrum ß Lactamases (ESbL) producing Escherichia coli
(Ec) and Klebsiella pneumoniae (KP) has increased in recent years leading to limitations of …

Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a …

D Schoevaerdts, P Bogaerts, A Grimmelprez… - BMC infectious …, 2011 - Springer
Background Description of the clinical pictures of patients colonized or infected by ESBL-
producing Enterobacteriaceae isolates and admitted to hospital are rather scarce in Europe …

High rates of intestinal colonization with extended-spectrum lactamase-producing Enterobacteriaceae among healthy individuals

EM Abdul Rahman… - Journal of Investigative …, 2011 - journals.sagepub.com
Background Infections caused by extended-spectrum β-lactamase (ESBL)-producing
bacteria become an emerging problem in the community setting in many parts of the world …

Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care Centers

C Arpin, V Dubois, L Coulange, C André… - Antimicrobial agents …, 2003 - Am Soc Microbiol
ABSTRACT In 1999, 39 of 2,599 isolates of the family Enterobacteriaceae (1.5%) collected
by eight private laboratories in the Aquitaine region in France produced an extended …

Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing …

JR Zahar, P Lesprit, S Ruckly, A Eden… - International journal of …, 2017 - Elsevier
Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are endemic
pathogens worldwide. Infection with ESBL-PE may be associated with inadequate antibiotic …

Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations

M Thouverez, D Talon, X Bertrand - Infection Control & Hospital …, 2004 - cambridge.org
Objective: To evaluate the usefulness of screening cultures in the control of extended-
spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in intensive care units …